STRONGSVILLE, Ohio & ALEXANDRIA, Va.--(BUSINESS WIRE)--Sparton Corporation’s (NYSE:SPA - News) wholly-owned subsidiary, Sparton Medical Systems, Inc, a specialized low volume/high complexity medical device contract manufacturer, and MPR Associates, an engineering firm dedicated to developing “first-of-a-kind” proprietary products combine their strengths for medical device customers to gain a competitive advantage in this tough but promising medical device industry.
The combination of MPR’s team of 170 engineers and scientists, who have developed a strong proven track record for producing innovative new Class II and III devices in as few as six months using a fixed budget approach, and Sparton Medical System’s proven validation process for complex medical device build and test procedures, compresses the time required to transfer complex products into commercial manufacturing – a great benefit to customers. In addition, the combination of MPR and Sparton’s knowledge assists in breaking through all the regulatory hurdles in order to distribute finished medical products quickly.
“Our strategic alliance with Sparton allows innovative medical device companies to outsource the complete development and manufacturing of new devices in a way that was never possible before. A lean virtual-company form of new product development is particularly appropriate for the current economic environment. Staffing up for new projects used to be a necessary evil. Now companies can hire project teams with over thirty years experience working together with absolute confidence,” according to Christian Haller, General Manager of MPR’s Product Development Division, further adding that MPR’s clients have received industry acclaim for the short development cycles and low costs.
“With MPRs responsiveness to meeting customer’s critical development goals and Sparton Medical’s ability to manufacture, test, and ship complex medical devices worldwide, medical device customers will have a well balanced offering to not only reduce timing and total costs but also limit the risks involved with launching such products,” said Kevin Webb, Business Development Manager, Sparton Medical Systems, Inc.
About Sparton Medical Systems, Inc.
Sparton Medical Systems, Inc, is a wholly owned subsidiary of the Sparton Corporation (NYSE:SPA - News), now in it’s 109th year, and provides electronic design and manufacturing services for highly regulated markets and is headquartered in Jackson, Michigan with six locations world-wide.
Sparton Medical Systems, Inc. is an FDA-registered and ISO 13485 contract design, development, and manufacturing company specializing in complex laboratory instrumentation and electromechanical point-of-care medical devices for OEMs and emerging medical technology companies. Beyond the product launch, the company adds value by managing service support, organizing reliability studies, and driving cost reductions for customers to gain a competitive advantage. The company is headquartered in Strongsville, Ohio with additional dedicated medical resources and capacity in DeLeon Springs, Florida.
About MPR Associates
MPR Associates is an S Corporation engineering services firm that was founded in 1964. The company is headquartered in Alexandria, Va., with branch offices in Houston, Texas; Clifton Park, N.Y. (near Albany); Bedminster, New Jersey, East Lyme, Connecticut; El Segundo, Calif. (near Los Angeles), and San Mateo, Calif. MPR maintains a staff of over 170 and actively recruits promising engineers and scientists from major U.S. colleges and universities.
MPR specializes in serving the nuclear power, energy, federal government and product development market segments, including medical device manufacturing and life sciences. The company supports clients in 46 countries and six continents. The company is responsible for more than 100 patents and “first-of-a-kind” products. For more information, please visit www.mpr.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in the Company’s most recent Form 10K and Form 10Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.
Contact:
Sparton Corporation Kevin Webb, 440-878-4630 KWebb@sparton.com or MPR Associates Larry Cundy, 703-519-0200 lcundy@mpr.com or Val Luginbill, 703-519-0200 vluginbill@mpr.com
